Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY-NC-ND 4.0BMC Bioinformatics

Attentive interpretable tabular learning (TabNet) for miRNA expression classification in cervical cancer and Alzheimer's disease

  1. 1Department of Computer Engineering, Hasan Kalyoncu University, Gaziantep, 27020 Turkey
  2. 2Department of Computer Engineering, Gaziantep University, Gaziantep, 27310 Turkey

Abstract

Background and Objective: The classification of RNA sequencing (RNA-seq) data presents a fundamental challenge in computational biomedicine: raw read counts are high-dimensional, over-dispersed, and heteroscedastic, requiring careful preprocessing before machine learning models can be applied. Existing deep learning approaches for RNA-seq classification have largely overlooked the tabular nature of genomic expression data and have offered limited embedded interpretability. This study proposes TabNet, an attentive interpretable tabular learning architecture, as a framework for miRNA-based disease classification and evaluates its performance and interpretability against three established baseline models.

Methods: Two publicly available miRNA expression datasets were examined: a cervical cancer cohort (58 samples, 714 miRNAs) and an Alzheimer's disease cohort (70 samples, 503 miRNAs). Raw count data were preprocessed following the MLSeq framework, encompassing DESeq median-ratio normalisation, near-zero variance filtering, supervised gene ranking based on DESeq differential expression analysis, and the DESeq variance-stabilising transformation (vst). Gene subsets corresponding to 5%, 10%, and 30% of the post-filtering feature space were evaluated. TabNet was benchmarked against eight baselines spanning four learning paradigms: a 1D Convolutional Neural Network (CNN), a Long Short-Term Memory network (LSTM), Extreme Gradient Boosting (XGBoost), Random Forest, ElasticNet-regularised logistic regression, a Multi-Layer Perceptron (MLP), the prior-fitted transformer TabPFN, and the inherently interpretable Explainable Boosting Machine (EBM). Each configuration was assessed over 50 independent random train/test splits (70%/30%) under a strict leakage-free protocol in which all preprocessing, hyperparameter selection, and early stopping relied exclusively on inner validation subsets of the training partitions; all metrics are reported as mean ± ± SD.

Results: Under the leakage-free protocol, a group of four methods reached a statistically indistinguishable accuracy ceiling: on the cervical cancer dataset, ElasticNet (95.06% ± ± 4.66), EBM (94.94% ± ± 4.60), TabPFN (94.71% ± ± 4.64), and Random Forest (94.35% ± ± 5.82); on the Alzheimer's disease dataset, TabPFN (70.86% ± ± 10.26), EBM (70.67% ± ± 12.67), and ElasticNet (70.48% ± ± 9.76) led. TabNet reached 85.18% ± ± 11.10 (cervical) and 64.38% ± ± 11.23 (Alzheimer's) at its respective best levels -- below the top tier, but with the distinctive property of producing sparse, instance-level attention explanations as part of its forward computation. Supplementary analyses showed that self-supervised pre-training conferred no significant benefit at these cohort sizes, that results were robust to the choice between supervised differential-expression and unsupervised variance feature ranking, and that instance-level attention patterns varied substantially across splits, supporting their use as illustrative rather than confirmatory evidence.

Conclusions: In rigorously leakage-controlled small-cohort miRNA classification, strongly regularised classical models, glass-box additive models, and prior-fitted transformers converge to the same accuracy ceiling, and no evaluated method -- including attention-based deep learning -- surpasses it. Within this landscape, TabNet remains distinctive as the only evaluated deep architecture whose sequential attention mechanism produces sparse instance-level miRNA attributions as an inherent part of prediction, offering a trade-off between embedded interpretability and a moderate accuracy cost that we quantify precisely. These results argue for protocol-first evaluation and calibrated claims when deep tabular models are applied to small transcriptomic cohorts.

Related

  1. Interpretable Deep Learning of Endogenous Fluorophore Concentration and Entropy for Lung Tissue Classification
    Z. Yin, M. Xu, L. Virany +1
    bioRxivPreprintAll rights reservedFull textBiophysicsbioRxiv
  2. Dysregulation of Expression of Nicotinic Acetylcholine Receptors and Ly6/uPAR Proteins in the Cingulate Gyrus of the Cerebral Cortex of Patients with Alzheimer's Disease.
    M L Bychkov, A G Ochneva, V M Ushakova +7
    Acta naturaePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  3. CPRISP: an interpretable deep learning framework predicting circRNA-RBP interactions and guiding therapeutic discovery in neurodegeneration
    Yongtian Wang, Jiahao Li, Xinmeng Liu +2
    Nature CommunicationsPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  4. Immune-related molecular links between asthma and Alzheimer’s disease identified by multi-omics, machine learning and single-cell analysis
    Li-jie Yang, Ni-shan Deng, Miao-juan Zhu +3
    Frontiers in cell and developmental biologyPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  5. LitGene: an interpretable transformer model integrating text and ontology for gene representation learning
    Oladimeji Macaulay, Ala Jararweh, David Arredondo +8
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
BibTeX
@article{haznedar2026attentive,
  title = {{Attentive interpretable tabular learning (TabNet) for miRNA expression classification in cervical cancer and Alzheimer's disease}},
  author = {Hilal Haznedar and Gözde Özsert Yiğit and Bülent Haznedar},
  journal = {BMC Bioinformatics},
  year = {2026},
  month = oct,
  doi = {10.1186/s12859-026-06706-7},
  url = {https://doi.org/10.1186/s12859-026-06706-7},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Attentive interpretable tabular learning (TabNet) for miRNA expression classification in cervical cancer and Alzheimer's disease
AU  - Hilal Haznedar
AU  - Gözde Özsert Yiğit
AU  - Bülent Haznedar
PY  - 2026
DA  - 2026/10/27
JO  - BMC Bioinformatics
DO  - 10.1186/s12859-026-06706-7
UR  - https://doi.org/10.1186/s12859-026-06706-7
AB  - Background and Objective: The classification of RNA sequencing (RNA-seq) data presents a fundamental challenge in computational biomedicine: raw read counts are high-dimensional, over-dispersed, and heteroscedastic, requiring careful preprocessing before machine learning models can be applied. Existing deep learning approaches for RNA-seq classification have largely overlooked the tabular nature of genomic expression data and have offered limited embedded interpretability. This study proposes TabNet, an attentive interpretable tabular learning architecture, as a framework for miRNA-based disease classification and evaluates its performance and interpretability against three established baseline models.  Methods: Two publicly available miRNA expression datasets were examined: a cervical cancer cohort (58 samples, 714 miRNAs) and an Alzheimer's disease cohort (70 samples, 503 miRNAs). Raw count data were preprocessed following the MLSeq framework, encompassing DESeq median-ratio normalisation, near-zero variance filtering, supervised gene ranking based on DESeq differential expression analysis, and the DESeq variance-stabilising transformation (vst). Gene subsets corresponding to 5%, 10%, and 30% of the post-filtering feature space were evaluated. TabNet was benchmarked against eight baselines spanning four learning paradigms: a 1D Convolutional Neural Network (CNN), a Long Short-Term Memory network (LSTM), Extreme Gradient Boosting (XGBoost), Random Forest, ElasticNet-regularised logistic regression, a Multi-Layer Perceptron (MLP), the prior-fitted transformer TabPFN, and the inherently interpretable Explainable Boosting Machine (EBM). Each configuration was assessed over 50 independent random train/test splits (70%/30%) under a strict leakage-free protocol in which all preprocessing, hyperparameter selection, and early stopping relied exclusively on inner validation subsets of the training partitions; all metrics are reported as mean ± ± SD.  Results: Under the leakage-free protocol, a group of four methods reached a statistically indistinguishable accuracy ceiling: on the cervical cancer dataset, ElasticNet (95.06% ± ± 4.66), EBM (94.94% ± ± 4.60), TabPFN (94.71% ± ± 4.64), and Random Forest (94.35% ± ± 5.82); on the Alzheimer's disease dataset, TabPFN (70.86% ± ± 10.26), EBM (70.67% ± ± 12.67), and ElasticNet (70.48% ± ± 9.76) led. TabNet reached 85.18% ± ± 11.10 (cervical) and 64.38% ± ± 11.23 (Alzheimer's) at its respective best levels -- below the top tier, but with the distinctive property of producing sparse, instance-level attention explanations as part of its forward computation. Supplementary analyses showed that self-supervised pre-training conferred no significant benefit at these cohort sizes, that results were robust to the choice between supervised differential-expression and unsupervised variance feature ranking, and that instance-level attention patterns varied substantially across splits, supporting their use as illustrative rather than confirmatory evidence.  Conclusions: In rigorously leakage-controlled small-cohort miRNA classification, strongly regularised classical models, glass-box additive models, and prior-fitted transformers converge to the same accuracy ceiling, and no evaluated method -- including attention-based deep learning -- surpasses it. Within this landscape, TabNet remains distinctive as the only evaluated deep architecture whose sequential attention mechanism produces sparse instance-level miRNA attributions as an inherent part of prediction, offering a trade-off between embedded interpretability and a moderate accuracy cost that we quantify precisely. These results argue for protocol-first evaluation and calibrated claims when deep tabular models are applied to small transcriptomic cohorts.
SN  - 1471-2105
ER  -